Insights
Publication | Pharmaceutical Compliance Monitor
Regulatory and Compliance Implications of Orphan Drugs
Edward J. Buthusiem and Gary F. Miller, Jr.
November 24, 2014
Edward Buthusiem and Gary Miller write about drug development and compliance, the Orphan Drug Act, and potential program incentives.